Multinationals & Service Providers | Kisaco Research

Multinationals & Service Providers

Animal Health, Nutrition and Technology Innovation Europe 2024
4-6 March, 2024
London, UK

Plan Your AHNTI Experience

At the forefront of innovation, our community of multinational animal health companies play a key role in shaping the investments and innovation happening in the animal health sphere. Our Service providers continue to support the entire ecosystem and include researchers, knowledge leaders, accelerators, consultants, lawyers, CROs, and regulatory experts.

Regardless of your interest level, species focus or service, we're certain to have an something suited to your needs!

Check out some of the opportunities at this year's summit below.

The Innovation Showcase returns for 2024!

This is your opportunity to present your company to 700 industry leaders, including the world's leading animal health companies, the industry's biggest investors, service providers, technology providers, and every potential collaborator you can think of! 

Back for its 9th year, previous presenting start-ups include Mileutis, who went on to secure $20M in product financing and PetMedix, who are in the process of being acquired by Zoetis. 

Our 16 2024 finalists will get the chance to present their brand to our entire global network of movers and shakers in animal health - you really can't afford to miss this! 

Our 16 Innovation Showcase finalsts have been announced! Please see the full list below

We're delighted to announce our Innovation Showcase finalists

Check out the 16 emerging companies chosen by our selection committee to present in  our companion and production animal showcases on 5-6 March!

Our selection committee have selected the 16 most innovative start-ups from our pool of applicants, to present in a 5 minute lightning pitch on the mainstage to our prestigious judging panel and audience of 700+ senior animal health executives.

VIEW OUR 2024 FINALISTS

Book a Dedicated Meeting Table

Do you want your own dedicated meeting space to host all your 1-2-1 meetings throughout the entire event?

Maximise your time onsite by booking your own, dedicated meeting table with up to four seats. This meeting table will be in our Networking Area and will be labelled with your company name to ensure people know where you are!

All tables are:

  • Labelled with your company name

  • Available to book meetings at on Swapcard App

  • Yours from 5-6 March

Why Partner With AHNTI EU?

This event is the leading strategic forum to create and strengthen relationships with the most influential companies and the most exciting innovators from across the animal health ecosystem. Partner with us to:

  • Boost your brand in front of the full animal health value chain

  • Scout out new potential partnerships whist consolidating
    current relationships

  • Be seen as a thought leader in front of an audience of over 350 animal health decision makers

For more information on the topics, audience, and event/digital opportunities available at the Animal Health, Nutrition & Technology Innovation Europe Summit, view our 2024 Agenda.

Women in Leadership Lunch

In honour of International Women’s Day on Friday 8th March, we will be hosting a lunch to celebrate the trailblazing women who are helping to drive forward the animal health industry.

In collaboration with Feather in Her Cap, this lunch is open to everyone in attendance and will include a keynote presentation focused on the power of communication styles.

Our inaugural WiL Lunch will be hosted by Julia Stephanus, Partner, Borealis Ventures & Founding Director, Feather in Her Cap

Species-Specific Roundtables

Join us for our Species-Specific Roundtables series, 6 deep-dives into the latest developments opportunities in animal health across specific species. 

Choose from any of these 6 intimate sessions, led by experts in their respective topics/fields. Also an additional networking opportunity, these roundtables across pre-registered groups of up to 12 people, across companion animals. Each interactive session is 30-minutes, giving you the opportunity to visit two roundtables.

.

Agenda Highlights


Author:

Dave Ross

Chief Executive Officer
Agri-EPI Centre Ltd

Dave Ross

Chief Executive Officer
Agri-EPI Centre Ltd

Author:

Emily Don

Head of Sustainability
Avara Foods

Emily Don

Head of Sustainability
Avara Foods

Author:

Judith Batchelar

Director
Food Matters International Ltd

Judith Batchelar

Director
Food Matters International Ltd

Author:

Aaron Schacht

CEO
BiomEdit

Prior to this role, Mr. Aaron Schacht was the Vice President of Global Research and Development / Regulatory Affairs at Elanco Animal Healthheld. Before that, he held the role of Global Brand Development Leader – Pain in Lilly Biomedicines. He was the global leader for product development and commercialization activities for LY2951742 – Lilly’s novel CGRP neutralizing antibody – a new potential treatment for prevention of Migraine and Cluster Headache. In 2012, Schacht joined Lilly Biomedicines as Senior Advisor – Strategy & Business Development for Lilly BioMedicines. His responsibilities included oversight of Therapeutic Strategy development, R&D Portfolio Management, and Business Development for Lilly BioMedicines – Lilly’s largest business unit. Past roles included serving as Executive Director, Global External R&D, at Eli Lilly and Company, where he was responsible for implementation of strategies which aim to leverage novel approaches to external partnerships to augment Lilly’s access to pharmaceutical innovation as well as Executive Director of LRL (Lilly Research Labs) Strategy, Portfolio Management and Project Management where he was responsible for strategic planning, R&D portfolio and project management. Prior to these roles, he was Director, Innovation Center in the eLilly organization where he focused on the exploration, incubation and implementation of new business models and capabilities relevant to the strategic evolution of the pharmaceutical industry. In 2002, during a short leave from Lilly, Mr. Schacht was co-founder, President and CEO of Artesian Therapeutics, a Gaithersburg, MD cardiovascular drug discovery start-up. Mr. Schacht began his career at Lilly in 1990 as a medicinal chemist, and spent 5 years in the laboratory working to discover pharmaceuticals to treat cardiovascular disorders. Schacht studied Organic chemistry at the University of Illinois, receiving his Bachelors of Science degree in 1990.

Aaron Schacht

CEO
BiomEdit

Prior to this role, Mr. Aaron Schacht was the Vice President of Global Research and Development / Regulatory Affairs at Elanco Animal Healthheld. Before that, he held the role of Global Brand Development Leader – Pain in Lilly Biomedicines. He was the global leader for product development and commercialization activities for LY2951742 – Lilly’s novel CGRP neutralizing antibody – a new potential treatment for prevention of Migraine and Cluster Headache. In 2012, Schacht joined Lilly Biomedicines as Senior Advisor – Strategy & Business Development for Lilly BioMedicines. His responsibilities included oversight of Therapeutic Strategy development, R&D Portfolio Management, and Business Development for Lilly BioMedicines – Lilly’s largest business unit. Past roles included serving as Executive Director, Global External R&D, at Eli Lilly and Company, where he was responsible for implementation of strategies which aim to leverage novel approaches to external partnerships to augment Lilly’s access to pharmaceutical innovation as well as Executive Director of LRL (Lilly Research Labs) Strategy, Portfolio Management and Project Management where he was responsible for strategic planning, R&D portfolio and project management. Prior to these roles, he was Director, Innovation Center in the eLilly organization where he focused on the exploration, incubation and implementation of new business models and capabilities relevant to the strategic evolution of the pharmaceutical industry. In 2002, during a short leave from Lilly, Mr. Schacht was co-founder, President and CEO of Artesian Therapeutics, a Gaithersburg, MD cardiovascular drug discovery start-up. Mr. Schacht began his career at Lilly in 1990 as a medicinal chemist, and spent 5 years in the laboratory working to discover pharmaceuticals to treat cardiovascular disorders. Schacht studied Organic chemistry at the University of Illinois, receiving his Bachelors of Science degree in 1990.

Author:

Rob Kelly

Senior Vice President, Commercial Leader for EURAM Region
MSD Animal Health

Rob Kelly

Senior Vice President, Commercial Leader for EURAM Region
MSD Animal Health

Interested in finding out more?

Download the agenda for the full list of sessions

view agenda

Don't just take it from us - here's what your peers had to say!

Who You Will Meet

The Animal Health, Nutrition and Technology Innovation Series is the premier, industry-led platform dedicated to uniting the entire industry. Bringing together senior executives from large pharmaceutical and medical device companies, biotechs, startups, investors, funds, CROs, consultants, law firms, government representatives, regulatory experts, and other supporting stakeholders, AHNTI is dedicated to meeting the essential demands of the animal health sector to facilitate the scaling and growth of companies and key stakeholders throughout their commercial journey.

  • Emerging Companies
    46%

    Past Start-Up Attendees

  • Investors
    12%

    Past Investor Attendees

  • Multinationals and Service Providers
    28%

    Past Multinational Attendees

  • Mid-Size Companies
    14%